Dose-finding Study of MCI-196

Stopped This study has been terminated because of insufficient patient recruitment.

Conditions

• Chronic Kidney Disease
• Dialysis
• Hyperphosphatemia
• Paediatric

Interventions

• DRUG: colestilan-L
• DRUG: colestilan-M
• DRUG: colestilan-H
• DRUG: CBPB

Sponsor

Tanabe Pharma Corporation